Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.82x is 280% above its 5-year average of -1.57x, around the middle of its 5-year range (-7.65x–8.29x).
As of the fiscal period ended Tuesday, June 30, 2026. 9.61% below its 12-month average of 3.12x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
2.82x
INTEREST COVERAGE RATIO AVG TTM
3.12x
INTEREST COVERAGE RATIO AVG 3Y
0.53x
INTEREST COVERAGE RATIO AVG 5Y
-1.57x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.61%
CURRENT VS 3Y AVG
+429.89%
CURRENT VS 5Y AVG
+279.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.96x
median of 80 covered companies
CURRENT VS SECTOR MEDIAN
-59.44%
vs the sector median at left
Alnylam Pharmaceuticals, Inc.
Market Cap
$31.73B
Interest Coverage Ratio
2.82x
TTM Avg
3.12x
3Y Avg
0.53x
5Y Avg
-1.57x
Market Cap
$31.99B
Interest Coverage Ratio
-11.24x
TTM Avg
4.28x
3Y Avg
3.30x
5Y Avg
3.63x
Market Cap
$32.28B
Interest Coverage Ratio
7.63x
TTM Avg
8.79x
3Y Avg
9.45x
5Y Avg
11.57x
Market Cap
$32.40B
Interest Coverage Ratio
6.14x
TTM Avg
5.67x
3Y Avg
11.29x
5Y Avg
26.04x
Market Cap
$32.42B
Interest Coverage Ratio
14.80x
TTM Avg
14.41x
3Y Avg
13.27x
5Y Avg
12.34x
Market Cap
$31.02B
Interest Coverage Ratio
12.84x
TTM Avg
11.03x
3Y Avg
12.05x
5Y Avg
13.28x
Market Cap
$29.83B
Interest Coverage Ratio
2.72x
TTM Avg
2.21x
3Y Avg
1.60x
5Y Avg
1.60x
Market Cap
$34.27B
Interest Coverage Ratio
49.83x
TTM Avg
40.70x
3Y Avg
32.97x
5Y Avg
24.93x
Market Cap
$34.86B
Interest Coverage Ratio
65.20x
TTM Avg
99.43x
3Y Avg
62.91x
5Y Avg
55.69x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | $31.73B | 2.82x | 3.12x | 0.53x | -1.57x |
| Centene Corp. (CNC)vs › | $31.99B | -11.24x | 4.28x | 3.30x | 3.63x |
| Biogen Inc. (BIIB)vs › | $32.28B | 7.63x | 8.79x | 9.45x | 11.57x |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.40B | 6.14x | 5.67x | 11.29x | 26.04x |
| Zoetis Inc. (ZTS)vs › | $32.42B | 14.80x | 14.41x | 13.27x | 12.34x |
| Waters Corporation (WAT)vs › | $31.02B | 12.84x | 11.03x | 12.05x | 13.28x |
| Medline Inc. (MDLN)vs › | $29.83B | 2.72x | 2.21x | 1.60x | 1.60x |
| DexCom, Inc. (DXCM)vs › | $34.27B | 49.83x | 40.70x | 32.97x | 24.93x |
| ResMed Inc. (RMD)vs › | $34.86B | 65.20x | 99.43x | 62.91x | 55.69x |
| Alcon Inc. (ALC)vs › | $35.12B | 6.67x | 7.13x | 6.15x | 5.89x |
Interest Coverage
2.8x
Debt/Equity
0.94
Current Ratio
3.05
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.82x |
| 2026-03-31 | 3.88x |
| 2025-12-31 | 1.02x |
| 2025-09-30 | 8.29x |
| 2025-06-30 | -0.40x |
| 2025-03-31 | 0.47x |
| 2024-12-31 | -2.70x |
| 2024-09-30 | -2.24x |
| 2024-06-30 | 1.46x |
| 2024-03-31 | -1.23x |
| 2023-12-31 | -3.71x |
| 2023-09-30 | 6.92x |
| 2023-06-30 | -7.65x |
| 2023-03-31 | -5.17x |
| 2022-12-31 | -6.31x |
| 2022-09-30 | -6.28x |
| 2022-06-30 | -4.50x |
| 2022-03-31 | -3.46x |
| 2021-12-31 | -5.28x |
| 2021-09-30 | -4.51x |
| 2021-06-30 | -4.37x |
| 2021-03-31 | -5.73x |
| 2020-12-31 | -6.81x |
| 2020-09-30 | -7.84x |
| 2020-06-30 | -7.30x |
